²ÝÁñÉçÇø

The emergency authorization, which FDA released Monday, allows the drug to be used in adults and children over the age of 12 with mild to moderate Covid-19 symptoms who are at high risk of progressing to severe disease or requiring hospitalization. Lilly has  from a late-stage trial showing that the antibody reduces the amount of virus in a person's body, and seems to speed recovery.